News

German drug agency approves mifepristone

BMJ 1999; 319 doi: https://doi.org/10.1136/bmj.319.7203.141a (Published 17 July 1999) Cite this as: BMJ 1999;319:141
  1. Annette Tuffs
  1. Heidelberg

    After more than 10 years of public debate, mifepristone will be available to women seeking abortions in Germany in a few months' time The Federal Drug Agency in Berlin announced last week that it had approved an application for sale of the drug from the French manufacturer, Laboratoires Exelgyn, Paris.

    As in France, mifepristone has been approved for use during the first seven weeks of pregnancy; use of mifepristone is to be followed by the insertion of …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe